Literature DB >> 34432487

Development of a Multiplex Bead Assay To Detect Immunoglobulin G Antibodies to Babesia duncani in Human Serum.

Yong Wang1,2, TaLesa Aderohunmu1,2, Henry Bishop2, Isabel McAuliffe2, Hilda N Rivera2, Darlyne Smith2, Patricia P Wilkins2, Katherine E Bowden2, Matthew S Reed3, Pavel Svoboda3, Olga Stuchlik3, Jan Pohl3, Ryan E Wiegand4, Sukwan Handali2.   

Abstract

Babesia duncani is the causative agent of babesiosis in the western United States. The indirect fluorescent antibody (IFA) assay is the diagnostic test of choice for detection of B. duncani-specific antibodies. However, this test requires parasitized red blood cells harvested from infected hamsters, and test results are often difficult to interpret. To simplify serological testing for B. duncani, a proteomics approach was employed to identify candidate immunodiagnostic antigens. Several proteins were identified by electrospray ionization mass spectrometric analysis, and four recombinant protein constructs were expressed and used in a multiplex bead assay (MBA) to detect B. duncani-specific antibodies. Two antigens, AAY83295.1 and AAY83296.1, performed well with high sensitivities and specificities. AAY83295.1 had a higher sensitivity (100%) but lower specificity (89%) than AAY83296.1, which had a sensitivity of 90% and a specificity of 96%. Combining these two antigens did not improve the performance of the assay. This MBA could be useful for diagnosis, serosurveillance, and blood donor screening for B. duncani infection.

Entities:  

Keywords:  Babesia duncani; antibody detection; immunoglobulin G; multiplex bead assay

Mesh:

Substances:

Year:  2021        PMID: 34432487      PMCID: PMC8525578          DOI: 10.1128/JCM.00458-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  The third described case of transfusion-transmitted Babesia duncani.

Authors:  Evan M Bloch; Barbara L Herwaldt; David A Leiby; Annette Shaieb; Ross M Herron; Michael Chervenak; William Reed; Robert Hunter; Rosilyn Ryals; Ward Hagar; Maniphet V Xayavong; Susan B Slemenda; Norman J Pieniazek; Patricia P Wilkins; Anne M Kjemtrup
Journal:  Transfusion       Date:  2011-12-13       Impact factor: 3.157

2.  SignalP 4.0: discriminating signal peptides from transmembrane regions.

Authors:  Thomas Nordahl Petersen; Søren Brunak; Gunnar von Heijne; Henrik Nielsen
Journal:  Nat Methods       Date:  2011-09-29       Impact factor: 28.547

3.  An Improved PCR Protocol For Detection of Babesia duncanI In Wildlife and Vector Samples.

Authors:  K E O'Connor; A M Kjemtrup; P A Conrad; A Swei
Journal:  J Parasitol       Date:  2018-05-15       Impact factor: 1.276

4.  An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium).

Authors:  V C Tsang; J A Brand; A E Boyer
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

5.  Superior real-time polymerase chain reaction detection of Babesia microti parasites in whole blood utilizing high-copy BMN antigens as amplification targets.

Authors:  Bryan Grabias; Jean Clement; Peter J Krause; Timothy Lepore; Sanjai Kumar
Journal:  Transfusion       Date:  2018-04-17       Impact factor: 3.157

6.  Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test.

Authors:  E S Chisholm; T K Ruebush; A J Sulzer; G R Healy
Journal:  Am J Trop Med Hyg       Date:  1978-01       Impact factor: 2.345

7.  Increasing health burden of human babesiosis in endemic sites.

Authors:  Peter J Krause; Kathleen McKay; Joseph Gadbaw; Diane Christianson; Linda Closter; Timothy Lepore; Sam R Telford; Vijay Sikand; Raymond Ryan; David Persing; Justin D Radolf; Andrew Spielman
Journal:  Am J Trop Med Hyg       Date:  2003-04       Impact factor: 2.345

8.  Infection with a babesia-like organism in northern California.

Authors:  D H Persing; B L Herwaldt; C Glaser; R S Lane; J W Thomford; D Mathiesen; P J Krause; D F Phillip; P A Conrad
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

9.  Development and persistence of antibody in persons infected with Babesia microti.

Authors:  T K Ruebush; E S Chisholm; A J Sulzer; G R Healy
Journal:  Am J Trop Med Hyg       Date:  1981-01       Impact factor: 2.345

10.  Screening for Babesia microti in the U.S. Blood Supply.

Authors:  Erin D Moritz; Colleen S Winton; Laura Tonnetti; Rebecca L Townsend; Victor P Berardi; Mary-Ellen Hewins; Karen E Weeks; Roger Y Dodd; Susan L Stramer
Journal:  N Engl J Med       Date:  2016-12-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.